FDA Import Refusal SCS-7773874-9/21/1 — Sanofi Aventis Recherche & Developpement
The FDA refused shipment SCS-7773874-9/21/1 from Sanofi Aventis Recherche & Developpement (France) on December 31, 2019. The refused product falls under Drugs and Biologics — GLIMEPIRIDE (ANTI-DIABETIC). Cited charges: 118,3280 This firm has 2 other import refusals on record.
Refusal Details
- Date
- December 31, 2019
- Country
- France
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA31 GLIMEPIRIDE (ANTI-DIABETIC)
- Charges
- 118,3280